Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer
Yaileen D. Guzmán‐Arocho, Shoshana M. Rosenberg, Judy E. Garber, Hilde Vardeh, Philip D. Poorvu, Kathryn J. Ruddy, Gregory J. Kirkner, Craig Snow, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Elena F. Brachtel, Jonathan D. Marotti, Ellen Warner, Ann H. Partridge, Laura C. Collins
Topics & Concepts
Breast cancerMedicineOncologyBRCA mutationGermline mutationInternal medicineCancerProspective cohort studyPopulationBiomarkerCohortHistopathologyMutationPathologyBiologyGeneticsGeneEnvironmental healthBRCA gene mutations in cancerBreast Cancer Treatment StudiesPARP inhibition in cancer therapy